51. Scleroderma Clinical trials / Disease details

Clinical trials : 525 /  Drugs : 565 - (DrugBank : 148) / Drug target genes : 114 - Drug target pathways : 217

  
2 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT05016804
(ClinicalTrials.gov)		July 4, 202217/8/2021Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic SclerosisSafety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Systemic SclerosisSystemic SclerosisBiological: AlloRxThe Foundation for Orthopaedics and Regenerative MedicineNULLRecruitingN/AN/AAll20Phase 1Antigua and Barbuda;Argentina;Mexico
2NCT05204784
(ClinicalTrials.gov)		February 28, 202229/11/2021Rheopheresis for Raynaud's and Digital Ulcers in Systemic SclerosisA Randomized Controlled Prospective Single-center Feasibility Study of Rheopheresis for Raynaud's Syndrome and Digital Ulcers in Systemic SclerosisSystemic Sclerosis;Raynaud Phenomenon;Digital Ulcer;SclerodermaProcedure: Rheopheresis treatment;Drug: Intravenous InfusionPeter KorstenDiaMed GmbHRecruiting18 YearsN/AAll30N/AGermany